Articulo aterosclerosis pdf

Con el tiempo, la placa se endurece y estrecha las arterias. A la larga, una zona de la placa puede romperse. Los investigadores siguen buscando las causas de la aterosclerosis. Esperan hallar respuestas a preguntas como las siguientes:. Todo aquello que aumente la probabilidad de tener una enfermedad se conoce como factor de riesgo.

Sin embargo, hay otros factores de riesgo que no se pueden controlar. Las causas son varias, entre ellas las crecientes tasas de obesidad infantil. Dejar de fumar.

Control de peso. Controlar su peso ayuda a controlar sus factores de riesgo para la aterosclerosis. Otro paso que usted puede tomar para ayudarle a prevenir o retardar la aterosclerosis es conocer sus antecedentes familiares de aterosclerosis. El dolor tiende a empeorar con la actividad y desaparece al descansar. La debilidad o ausencia del pulso puede ser un signo de que hay una arteria bloqueada.

Las concentraciones anormales pueden indicar que usted corre riesgo de sufrir aterosclerosis. La prueba puede mostrar el endurecimiento y estrechamiento de las grandes arterias. Esto puede ser un signo temprano de la enfermedad coronaria. Los objetivos del tratamiento incluyen:. Algunas veces los cambios en el estilo de vida no son suficientes para controlar los niveles de colesterol. Adoptar un estilo de vida saludable puede servirle para prevenir o retrasar la aterosclerosis y los problemas causados por ella.

Los investigadores siguen buscando formas de mejorar la salud de las personas que tienen aterosclerosis o que pueden llegar a presentarla. Vea todos los ensayos en ClinicalTrials. Read in English.

See also. Otros nombres para la aterosclerosis - Aterosclerosis. Arteriosclerosis Endurecimiento de las arterias. Principales factores de riesgo Las concentraciones poco saludables de colesterol en la sangre. La resistencia a la insulina. La resistencia a la insulina puede causar diabetes.

La diabetes. En esta enfermedad las concentraciones de glucosa en la sangre son demasiado altas porque el organismo no produce suficiente insulina o no usa la insulina adecuadamente. N Engl J Med, , pp. Prevalence of cardiovascular risk factors in the Spanish working population..

Rev Esp Cardiol, 59 , pp. High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study.. Arteriosclerosis, 8 , pp.

Blood pressure, systolic and diastolic, and cardiovascular risks. US population data.. Arch Intern Med, , pp. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias..

Hypertension magnitude and management in the elderly population of Spain.. J Hypertens, 20 , pp. Cigarette smoking and mortality risk: twenty-five-year follow-up of the Seven Countries Study.. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes..

Passive smoking and the risk of coronary heart disease: a meta-analysis of epidemiologic studies.. The risk of myocardial infarction after quitting smoking in men under 55 years of age.. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up..

Tablas de riesgo para diab?? Son realmente necesarias? Preexisting cardiovascular conditions and long-term prognosis after initial myocardial infarction: the Framingham Study..

Am Heart J, , pp. Myocardial infarction in the elderly. Comparison between 2 groups of patients over 75 and under 65 years of age.. Ann Cardiol Angeiol Paris , 46 , pp. Relation of coronary artery disease to atherosclerotic disease in the aorta, carotid, and femoral arteries evaluated by ultrasound..

Am J Cardiol, 80 , pp. Manifestations of coronary disease predisposing to stroke. Predisposing factors for cerebral infarction: the Oxfordshire community stroke project.. BMJ, , pp. Relationship of cardiac disease to stroke occurrence, recurrence, and mortality..

Stroke, 23 , pp. The Lausanne Stroke Registry: analysis of 1, consecutive patients with first stroke.. Stroke, 19 , pp. Rev Clin Esp, , pp.

The epidemiology of peripheral arterial disease: importance of identifying the population at risk.. Vasc Med, 2 , pp. Mortality over a period of 10 years in patients with peripheral arterial disease.. Eur J Vasc Endovasc Surg, 30 , pp. Eur Heart J, 24 , pp. C-reactive protein and cardiovascular disease risk:still an unknown quantity? Ann Intern Med, , pp. High-sensitivity C-reactive protein: clinical importance.. Curr Probl Cardiol, 29 , pp.

Clinical application of C-reactive protein for cardiovascular disease detection and prevention.. Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study.. Arterioscler Thromb Vasc Biol, 22 , pp.

C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study.. C-reactive protein levels and outcomes after statin therapy.. Narrative review: assessment of C-reactive protein in risk prediction for cardiovascular disease.. The effect of including C-reactive protein in cardiovascular risk prediction models for women.. Metabolic syndrome and asymptomatic peripheral artery disease in subjects over 60 years of age..

Diabetes Care, 29 , pp. Association of ankle-brachial index and plaques in the carotid and femoral arteries with cardiovascular events and total mortality in a population-based study with 13 years of follow-up.. Eur Heart J, 27 , pp. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study..

Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group.. Arterioscler Thromb Vasc Biol, 19 , pp. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study.. Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study..

Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study..

Peripheral arterial disease in people with diabetes.. Diabetes Care, 26 , pp. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Resultados a largo plazo de un programa de Aida Ribera.